drugset / Trial / NCT05558410
Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to evaluate the efficacy and safety of Suzetrigine (SUZ) in treating acute pain after an abdominoplasty.
Timeline
- Start
- 2022-10-10
- Primary completion
- 2023-08-25
- Completion
- 2023-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 325 mg | Oral |
| Subject | Suzetrigine | Small molecule | 50 mg | Oral |
| Comparator | hydrocodone bitartrate | Unknown | 5 mg | Oral |
Indications
No indication recorded.